BDI
Balance
Diagnostic
Imaging
AlgoSensus was formed to leverage our technological expertise in AI, Machine Learning, and Robotics to focus on healthcare applications including health information, data science, and medical devices. Born out of years of research, our innovations include a novel method to diagnose a range of neuromuscular afflictions using our proprietary AI based software applications and devices. Our first product launch, the Kinezio Balance Measurement System identifies balance inadequacies due to neuromuscular deficiencies and offers a complete solution for treatment that improves outcomes dramatically.
Harnessing AlgoSensus' unique data from our proprietary Kinezio (Balance Algorithms) sensors and advanced AI technology, we are developing cutting-edge predictive diagnostics based on simple medical devices which will reduce the dependencies on MRIs. These simple devices combined with our unique AI solutions enable precise assessments of brain functionality and stability. By integrating IoT and Big Data, we deliver solutions that drive better treatment protocols and outcomes for falls among the elderly and across a variety of diseases such as Parkinson's, Alzheimer's, etc.
A world leader in predictive diagnostics, leveraging advanced AI, Balance Algorithms, and IoT technology to revolutionize the detection and management of chronic diseases, while improving treatment outcomes and enhancing lives globally.
Using unique data extracted from force sensors (our unique Kinezio technology), we measure stability and gravitational balance creating a unique and individual topographic map. As our balance is controlled and monitored by an intricate relationship between peripheral, vestibular and brain networks, we have developed advanced AI technology that enables us to manipulate data to assess brain performance and functionality with precision, based on simple medical devices.
Identifies subtle issues early, allowing for proactive measures to prevent falls.
Utilizes sensors and algorithms to generate precise measurements and insights.
Offers tailored interventions and exercise programs to improve stability.
Provides a holistic evaluation of factors contributing to instability.
Hyper-personalized balance analytics for clinical and at-home use Dynamic system that constantly improves via global data collection (most competitors provide only on-device solutions) Provides a complete solution – from assessment through personalized treatment with physical exercises and Reaction Time Training (Reflex) Moderate Price Point Reducing Barrier to Entry/Expand Market Adoption
Traditional balance assessments rely on subjective physical evaluations or limited instrumentation, often lacking precision and depth. AlgoSensus revolutionizes this space by combining IoT, AI-driven Big Data, and proprietary algorithms to target the neurological roots of instability. Our cutting-edge approach delivers the industry’s most precise and impactful balance assessments, including advanced reflex (reaction time) analysis.
Executive Chairman
Serial entrepreneur with 40+ years of experience scaling technology, retail, and medical-device companies globally, leading IPOs and M&As with Fortune 500 acquirers.
CEO
Over 35 years as a senior executive in private and public companies, leading M&As, NASDAQ IPOs, and ventures in retail and healthcare technologies, including serving as CEO of Shekel Scales and a senior executive at a U.S. Investment Bank’s Israel branch.
COO
New York-based financial, marketing, and operations executive with Fortune 100 experience and entrepreneurial expertise. Founded the U.S.’s first direct broadcast satellite radio network and led its NASDAQ IPO. Former CEO of Digital Lightwave, Inc. (NASDAQ), Chairman of NUR Macroprinters (NASDAQ/Israel), and Brand Consultant to Dubai-based Apparel UAE.
CPO
Experienced business development professional with expertise in healthcare and technology, leading multidisciplinary teams, strategic development, regulatory compliance, and business strategy. Holds an MBA and M.Sc. in Medical Sciences (magna cum laude) from Tel Aviv University and a B.Sc. in Life Sciences (cum laude) from Bar-Ilan University.
Director of Business Development
30+ years of experience in global medical equipment. Successfully launched new medical technology and developed winning strategies.
Head of AI Engineering
Over a decade of experience as an algorithm developer and data scientist, specializing in AI load cells and the intersection of machine learning and cyber technologies.
Senior Neurologist
Movement disorders specialist with extensive scientific and clinical experience in Israel, the UK, and the US. Director of the Neuromodulation and Deep Brain Stimulation Service at Rabin Medical Center. Holds an MBBS/MD from University College London (UCL) and a B.Sc. in Neuroscience (Distinction) from King’s College London.